A股收評:滬指四連陽創業板指漲2.76%,白酒板塊集體爆發
兩市高開高走,滬指全天收漲1.01%報3155.22點,為連續第4個交易日上漲1%,深成指、創業板指分別漲2.13%、2.76%。兩市3010股上漲,1780股下跌,成交額8420億,北上資金淨流入155.15億。

盤面上,行業板塊多數上漲,大消費板塊表現突出,釀酒板塊大幅領漲,古井貢酒漲停,瀘州老窖、五糧液漲約6%,茅台漲超4%重返1800元;家電、汽車、醫藥等板塊漲幅靠前,德賽西威等股漲停;新能源賽道股回暖,儲能、鋰電池、光伏等概念活躍,恩捷股份等多股漲停,寧德時代漲6%;券商股全線上漲,東方財富漲5%。供銷社、預製菜、免税等概念低迷。
具體來看:
白酒板塊表現活躍,古井貢酒漲停逼近歷史新高,迎駕貢酒漲8.69%,瀘州老窖、口子窖漲超6%,五糧液、洋河股份、捨得酒業漲超5%,貴州茅台漲4.41%股價一度重新站上1800元關口,酒鬼酒、山西汾酒紛紛上漲。

國泰君安發佈研究報吿稱,消費修復更加樂觀,宏觀政策紅利有望助力消費振興。白酒開門紅平穩推進,悲觀預期充分下春節動銷表現有望超預期改善,目前階段低估值白酒成為配置重點,中期恢復階段加配成長性,長期堅守龍頭酒企。一方面,當下渠道端仍保持較好韌性,整體庫存水平壓力相對可控,其中高端和區域酒庫存水平較低。另一方面,消費復甦有望提前到來,春節動銷趨勢值得期待。
鈉離子電池概念股走強,派能科技漲超11%,同興環保漲停,星源材質漲8.42%,寧德時代漲超6%股價重回400元,傳藝科技、鼎盛新材漲超4%。

醫藥股震盪走強,CRO方向領漲,皓元醫藥漲7.52%,泰格醫藥、美迪西、藥明康德漲超6%,康龍化成漲4.18%,昭衍新藥、和元生物、百誠醫藥漲超3%。

鹽湖提鋰板塊普漲,藍曉科技漲7.86%,華友鈷業漲6.06%,久吾高科、億緯鋰能漲超4%,西藏礦業、盛新鋰能、天齊鋰業漲超3%。

自然資源部部長王廣華表示,我國一些重要礦產資源對外依存度高,國際形勢一旦出現變化,必然影響經濟安全甚至是國家安全。對此,一方面要推進高水平對外開放,用好“兩種資源、兩個市場”;另一方面要未雨綢繆,做好特殊情況下的國內資源安全保障。我們將突出緊缺和大宗戰略性礦產,全面啟動新一輪戰略性礦產國內找礦行動。
券商股全線上漲,湘財股份領漲,國金證券、東方財富漲超5%,國聯證券漲4.2%。

零售板塊跌幅居前,新華百貨跌停,友阿股份跌6.78%,國光連鎖跌5.22%,南寧百貨、東百集團跌超4%。

供銷社概念普跌,天鵝股份跌6.7%,天禾股份跌4.09%,中農聯合、湖南發展等紛紛下跌。

北向資金方面,北上資金淨流入155.15億元,其中滬股通淨流入68.36億元,深股通淨流入86.79億元。

展望後市,光大證券指出,節後市場交投意願進入回升期,成交量明顯回升是增量入場的信號,這個久違的信號是市場恢復活躍的表現。當然,成交量與市場偏好能否持續回升,需要密切留意。市場底部夯實,風險偏好進入回升期。消費復甦邏輯不變,但消費股節前炒作太多,短期需要消化獲利盤,遇到回調可以繼續關注。短期可以沿着風險偏好的方向尋找交易機會,可以重點關注軟件服務、風電、食品等方向。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.